Evoq Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/05/2026 ,inter alia, to consider and approve Intimation of Board Meeting to ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Evoq Remedies Ltd has informed BSE that its Board of Directors will meet on May 14, 2026 to consider and approve the Audited Financial Results for the half year and full year ended March 31, 2026, along with the Auditor's Report. The meeting will be held at the company's registered office in Ahmedabad. This is a routine board meeting intimation filed under SEBI (LODR) Regulation 29(1) and does not contain any specific agenda items or disclosures beyond the standard financial results approval.
This is a standard pre-scheduled board meeting notice for annual financial results. It marks the beginning of the results announcement process and is routine in nature. No specific impact on shareholders can be determined until the actual financial results are released.